KIT and gastrointestinal stromal tumor: [Given the data supporting the use of a higher dose of imatinib (800 mg daily) in the presence of an exon 9 KIT variant in advanced GIST, clinicians might consider using this dose in the adjuvant setting for this genotype [46–48].